Companies: 10,795·Total market cap: $144.5T
Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals, Inc.

ADILNASDAQHealthcare● Active
$2.21
+$0.00(+0.00%)
Market Cap$2120813
P/E Ratio
52W High$19
52W Low$1.31
Overview

Adial Pharmaceuticals, Inc. (ADIL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ADIL · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-9.78adil eps ttm · adil earnings per shareEarnings history
PE Ratio (TTM)adil pe ratio ttm · adil price to earningsPE Ratio deep dive
Revenue (TTM)0.00adil revenue ttm · adil annual revenueFull revenue history
Dividend YieldNo Dividenddoes adil pay dividends · adil dividend yieldDividend history
Shares Outstanding668,630adil shares outstanding · adil floatShares outstanding history
Next EarningsAug 12, 2026Est.adil earnings date · adil next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
adial pharmaceuticals, inc. revenue · adil revenue 2025
FY 2025Net Income-$8.0M▲ +39.56% YoY
202320242025
adial pharmaceuticals, inc. net income · adil profit 2025
FY 2025EPS$-11.93▲ +32.79% YoY
202320242025
adil eps · adial pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$7.8MEPS: $-9.78View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis adil a buy · adil analyst rating
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$8.00Low
$2.21Current
$8.00Avg Target261.99% upside
$8.00High
adil price target · adil 12 month forecast

Total: 3 · Buy rate: 100.0%

The ADIL analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +261.99% upside from the current price of $2.21.

Stock Performance

Full History
1D+0.00%
1W-5.56%
1M+54.55%
3M+20.77%
YTD-59.82%
1Y-84.49%
5Y-99.88%

About Adial Pharmaceuticals, Inc.

CEOCary John Claiborne
IPO DateJul 27, 2018
Employees5
CountryUS

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention …

what is adial pharmaceuticals, inc. · adil stock overview · adial pharmaceuticals, inc. company profile · who is adial pharmaceuticals, inc. ceo · adil NASDAQ · adial pharmaceuticals, inc. headquarters · adial pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Adial Pharmaceuticals, Inc. (ADIL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 27, 2018. As of the latest trading session, ADIL stock price is $2.21, with a market capitalization of $2.1M. The stock has returned -84.49% over the past 12 months and -59.82% year-to-date.

According to 3 Wall Street analysts, the consensus rating for Adial Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, Adial Pharmaceuticals, Inc. reported revenue of — and net income of -$8.0M. For detailed data — including Adial Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Adial Pharmaceuticals, Inc. (ADIL) stock price is $2.21. The stock is traded on NASDAQ under the ticker symbol ADIL. The 52-week range is $1.31 – $19.00.

ADIL stock priceADIL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice